Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2025-12-26 @ 1:52 AM
NCT ID: NCT02303405
Description: None
Frequency Threshold: 0
Time Frame: 4 months
Study: NCT02303405
Study Brief: Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pioglitazone Treatment with pioglitazone 45 mg po (1 tablet) once daily x 4 months Pioglitazone: Anti-hyperglycemic agent 0 None 0 7 1 7 View
Hydroxychloroquine Treatment with hydroxychloroquine 400 mg (2 x 200 mg tablets) po once daily x 4 months Hydroxychloroquine: Anti-inflammatory and anti-malarial agent 0 None 1 15 0 15 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Transient Ischemic Attack SYSTEMATIC_ASSESSMENT Vascular disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Pedal Edema SYSTEMATIC_ASSESSMENT Vascular disorders None View